Zuclopenthixol: a new generation of antipsychotic drugs. An open clinical trial.
Author: Matar AM, Abdel Mawgoud M, Skov S.
Source:
Journal of clinical psychopharmacology, 10(4), 283-286.
Fifteen patients (20-49 years of age) with mania or acute psychosis were treated with zuclopenthixol acetate (Clopixol, Acuphase). One injection of 75-100 mg produced significant amelioration of psychotic symptoms with minimal side effects. The duration of action of the drug was found to be about 72 hours.